Hernan's questions to Afya Ltd (AFYA) leadership • Q2 2025
Question
Hernan from Citibank noted the significant year-over-year drop in the 'residency journey' student numbers and asked if this represented a market trend. He also asked for management's thoughts on the new 'Enamed' exams and any potential CapEx requirements.
Answer
CEO Virgilio Gibbon explained that the decline in residency journey students stemmed from a weak intake cycle in 2024 and that the main intake season for the current year is still ahead in Q3 and Q4. He described the new Enamed exam as a significant growth opportunity that will require only marginal CapEx, as Afya can leverage existing assets and content from its residency prep courses for both B2C and B2B markets.